The MRC-ILA-Heart study (37), which included 182 patients experiencing small acute myocardial infarction (AMI), revealed that NLRP3 inflammasome activation and the heightened IL-1 activity during the acute phase of myocardial infarction correlated with escalating heart failure risk. The gene discussed is NLRP3; the disease is myocardial infarction.